Safety and Efficacy of IQP-AK-102 in Reducing Appetite

Clinical trial NCT02041754 · COMPLETED

Trial details

NCT number: NCT02041754
Sponsor: InQpharm Group
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Weight Loss Appetite Modulation (Focus of Study)

Start date: 2014-01-01
Primary completion: 2014-08-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.